According to a new study in TRANSFUSION, the number of individuals in the U.S. who are eligible to donate blood may be smaller than previously believed – approximately 60 million fewer people. The new figures suggest that only 37 percent of the U.S. population is currently eligible to donate blood, and with anticipated demographic changes, that percentage is likely to drop.
“The conventional method of calculating eligible donors indicates that there are approximately 177 million eligible donors in the U.S. population,” said Jeffrey McCullough, one of the world’s leaders in transfusion medicine and blood banking. “This study indicates that only 111 million individuals in the U.S. are eligible to donate blood.”
Efforts to ensure donor and recipient safety have reduced the population of eligible voluntary blood donors. The current method for determining eligible blood donors focuses exclusively on age criteria. The lower eligible donor pool estimates as described in this study are based on a more stringent model that excludes individuals from donation due to such factors as high-risk behavior, disease exposure, presence of chronic diseases and age.
“As additional donor restrictions are implemented and the population ages, the country could lose more and more willing donors, which could pose an even greater threat to our national blood supply,” said Karen Shoos Lipton, chief executive officer of AABB. “Ensuring an adequate supply of blood is increasingly more challenging, and these new data suggest it is extremely important that eligible donors give blood more frequently.”
Dr. Jeffrey McCullough is Professor of Laboratory Medicine and Pathology; American Red Cross Chair, Transfusion Medicine; and Director of the Biomedical Engineering Institute; at the University of Minnesota. He can be reached for questions at mccul001umn.
TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning tissue transplantation and hematopoietic, cellular, and gene therapies. For more information, please visit blackwellpublishing/trf
About AABB
Established in 1947, AABB (formerly known as the American Association of Blood Banks) is an international, not-for-profit association dedicated to the advancement of science and the practice of transfusion medicine and related biological therapies. The association is committed to improving health by developing and delivering standards, accreditation and educational programs and services to optimize patient and donor care and safety. AABB membership consists of approximately 1,800 institutions and 8,000 individuals, including physicians, scientists, administrators, medical technologists, nurses, researchers, blood donor recruiters and public relations personnel. Members are located in all 50 states and 80 countries.
Wiley-Blackwell was formed in February 2007 as a result of the merger between Blackwell Publishing Ltd. and John Wiley & Sons, Inc.’s Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,250 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit blackwellpublishing or interscience.wiley.